Skip to main content

Diffuse Panbronchiolitis

  • Living reference work entry
  • First Online:
  • 768 Accesses

Synonyms

DPB

Definition

Diffuse panbronchiolitis (DPB) is an inflammatory lung disease, characterized by the chronic inflammation of bronchioles (small airways) in both lungs (Homma et al. 1983). The term diffuse means that lesions appear throughout both lungs, while panbronchiolitis refers to inflammation found in the respiratory bronchioles. DPB causes severe coughing, large amounts of sputum, and exertional breathlessness, often associated with chronic sinusitis, ultimately leading to respiratory failure. Histopathologically, thickened walls of terminal bronchioles, with infiltration of lymphocytes, plasma cells, and foamy macrophages, leading to chronic neutrophilic inflammatory airway disease, are the predominant features (Homma et al. 2006). Eventually, DPB develops into bronchiectasis, if left untreated, and the result will be fatal. The disease was first described by a Japanese group of clinicians as a new entity in the 1960s. It had not been accepted internationally because...

This is a preview of subscription content, log in via an institution.

References

  • Akira, M., Kitatani, F., Lee, Y. S., Kita, N., Yamamoto, S., Higashihara, T., et al. (1988). Diffuse panbronchiolitis: evaluation with high-resolution CT. Radiology, 168(2), 433–438.

    Article  CAS  PubMed  Google Scholar 

  • Anthony, M., Singham, S., Soans, B., & Tyler, G. (2009). Diffuse panbronchiolitis: not just an Asian disease: Australian case series and review of the literature. Biomedical Imaging and Intervention Journal, 5(4), e19.

    Article  PubMed  PubMed Central  Google Scholar 

  • Homma, H. (1986). Diffuse panbronchiolitis. Japanese Journal of Medicine, 25(3), 329–334.

    Article  CAS  PubMed  Google Scholar 

  • Homma, H., Yamanaka, A., Tanimoto, S., Tamura, M., Chijimatsu, Y., Kira, S., et al. (1983). Diffuse panbronchiolitis. A disease of the transitional zone of the lung. Chest, 83(1), 63–69.

    Article  CAS  PubMed  Google Scholar 

  • Homma, S., Sakamoto, S., Kawabata, M., Kishi, K., Tsuboi, E., Motoi, N., et al. (2006). Comparative clinicopathology of obliterative bronchiolitis and diffuse panbronchiolitis. Respiration, 73(4), 481–487.

    Article  PubMed  Google Scholar 

  • Izumi, T., Doi, O., Nobechi, A., et al. (1983). Nation-wide survey of diffuse panbronchiolitis. Annual report on the study of interstitial lung disease in 1982 (pp 3–41). Grant-in aid from the Ministry of Health and Welfare of Japan, Tokyo.

    Google Scholar 

  • Kadota, J., Mukae, H., Ishii, H., Nagata, T., Kaida, H., Tomono, K., et al. (2003). Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis. Respiratory Medicine, 97(7), 844–850.

    Article  CAS  PubMed  Google Scholar 

  • Keicho, N., & Hijikata, M. (2011). Genetic predisposition to diffuse panbronchiolitis. Respirology, 16(4), 581–588.

    Article  PubMed  Google Scholar 

  • Keicho, N., Ohashi, J., Tamiya, G., Nakata, K., Taguchi, Y., Azuma, A., et al. (2000). Fine localization of a major disease-susceptibility locus for diffuse panbronchiolitis. American Journal of Human Genetics, 66(2), 501–507.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kudoh, S., Azuma, A., Yamamoto, M., Izumi, T., & Ando, M. (1998). Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. American Journal of Respiratory and Critical Care Medicine, 157(6 Pt 1), 1829–1832.

    Article  CAS  PubMed  Google Scholar 

  • Mukae, H., Kadota, J., Kohno, S., Kusano, S., Morikawa, T., Matsukura, S., et al. (1995). Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis. American Journal of Respiratory and Critical Care Medicine, 152(2), 613–618.

    Article  CAS  PubMed  Google Scholar 

  • Nakata, K. (1999). Revision of clinical guidelines for DPB (in Japanese). Annual Report on the study of diffuse lung disease in 1998 (pp.109–11). Tokyo: Ministry of Health and Welfare of Japan.

    Google Scholar 

  • Nakata, K., Taguchi, Y., & Kudoh, S. (2000). Therapeutic guidelines for DPB (in Japanese). Annual report on the study of diffuse lung disease in 1999 (p. 11). Tokyo: Ministry of Health and Welfare of Japan.

    Google Scholar 

  • Okada M, Saito, N., Hosoda, Y. et al. (1980). An Epidemiological study of DPB in a large Company. Annual Report on the study of interstitial lung disease in 1980 (pp. 25–28). Grant-in Aid from the Ministry of Health and Welfare of Japan, Tokyo, Japan.

    Google Scholar 

  • Park, M. H., Kim, Y. W., Yoon, H. I., Yoo, C. G., Han, S. K., Shim, Y. S., et al. (1999). Association of HLA class I antigens with diffuse panbronchiolitis in Korean patients. American Journal of Respiratory and Critical Care Medicine, 159(2), 526–529.

    Article  CAS  PubMed  Google Scholar 

  • Parnham, M. J., Culic, O., Erakovic, V., Munic, V., Popovic-Grle, S., Barisic, K., et al. (2005). Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment. European Journal of Pharmacology, 517(1–2), 132–143.

    Article  CAS  PubMed  Google Scholar 

  • Parnham, M. J., Erakovic Haber, V., Giamarellos-Bourboulis, E. J., Perletti, G., Verleden, G. M., & Vos, R. (2014). Azithromycin: mechanisms of action and their relevance for clinical applications. Pharmacology and Therapeutics, 143(2), 225–245.

    Article  CAS  PubMed  Google Scholar 

  • Poletti, V., Casoni, G., Chilosi, M., & Zompatori, M. (2006). Diffuse panbronchiolitis. European Respiratory Journal, 28(4), 862–871.

    Article  CAS  PubMed  Google Scholar 

  • Shinkai, M., Foster, G. H., & Rubin, B. K. (2006a). Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology, 290(1), L75–L85.

    Article  CAS  PubMed  Google Scholar 

  • Shinkai, M., Tamaoki, J., Kobayashi, H., Kanoh, S., Motoyoshi, K., Kute, T., et al. (2006b). Clarithromycin delays progression of bronchial epithelial cells from G1 phase to S phase and delays cell growth via extracellular signal-regulated protein kinase suppression. Antimicrobial Agents and Chemotherapy, 50(5), 1738–1744.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shinkai, M., Lopez-Boado, Y. S., & Rubin, B. K. (2007). Clarithromycin has an immunomodulatory effect on ERK-mediated inflammation induced by Pseudomonas aeruginosa flagellin. Journal of Antimicrobial Chemotherapy, 59(6), 1096–1101.

    Article  CAS  PubMed  Google Scholar 

  • Shinkai, M., Henke, M. O., & Rubin, B. K. (2008). Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action. Pharmacology and Therapeutics, 117(3), 393–405.

    Article  CAS  PubMed  Google Scholar 

  • Sugiyama, Y. (1993). Diffuse panbronchiolitis. Clinics in Chest Medicine, 14(4), 765–772.

    CAS  PubMed  Google Scholar 

  • Yamanaka, A., Saiki, S., Tamura, S., & Saito, K. (1969). Problems in chronic obstructive bronchial diseases, with special reference to diffuse panbronchiolitis. Naika, 23, 442–451.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Masaharu Shinkai or Yoriko Inoue .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Basel

About this entry

Cite this entry

Shinkai, M., Inoue, Y. (2016). Diffuse Panbronchiolitis. In: Parnham, M. (eds) Encyclopedia of Inflammatory Diseases. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-0620-6_190-2

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-0620-6_190-2

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Birkhäuser, Basel

  • Online ISBN: 978-3-0348-0620-6

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics